Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Cairo University

Cairo University in Cairo, Egypt is listed as a site for 519 registered clinical trials, 127 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 519
Ongoing 127

This page covers the site record Cairo University in Cairo, Egypt: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Cairo University, also sponsors trials.

Get the Cairo University report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 519 trials counted.

  • Phase 1 18 trials
  • Phase 1/2 4 trials
  • Phase 2 8 trials
  • Phase 2/3 8 trials
  • Phase 3 21 trials
  • Phase 4 34 trials
  • Not applicable 331 trials
  • Observational 94 trials
  • Expanded access 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 128 trials
  • Completed 244 trials
  • Terminated 6 trials
  • Other 141 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 73

2001: 1 trials (Not applicable 1) 2006: 1 trials (Not applicable 1) 2010: 2 trials (Not applicable 1, Phase 2/3 1) 2011: 1 trials (Not applicable 1) 2012: 1 trials (Not applicable 1) 2013: 3 trials (Not applicable 1, Phase 3 1, Phase 1 1) 2014: 1 trials (Phase 4 1) 2015: 4 trials (Observational 1, Phase 4 2, Phase 2/3 1) 2016: 7 trials (Not applicable 4, Phase 4 2, Phase 2/3 1) 2017: 32 trials (Observational 9, Not applicable 11, Phase 4 8, Phase 3 1, Phase 2/3 1, Phase 2 1, Phase 1/2 1) 2018: 50 trials (Observational 14, Not applicable 26, Phase 4 3, Phase 3 3, Phase 2 1, Phase 1/2 1, Phase 1 2) 2019: 45 trials (Observational 10, Not applicable 25, Phase 4 4, Phase 3 4, Phase 2/3 1, Phase 1 1) 2020: 46 trials (Observational 15, Not applicable 20, Phase 4 1, Phase 3 4, Phase 2/3 1, Phase 2 2, Phase 1 3) 2021: 41 trials (Observational 4, Not applicable 26, Phase 4 3, Phase 3 1, Phase 2/3 1, Phase 2 1, Phase 1/2 1, Phase 1 4) 2022: 58 trials (Observational 9, Not applicable 42, Phase 4 4, Phase 3 1, Phase 2 1, Phase 1 1) 2023: 51 trials (Observational 8, Not applicable 35, Phase 4 3, Phase 3 2, Phase 2/3 1, Phase 1 2) 2024: 73 trials (Observational 10, Not applicable 55, Phase 4 1, Phase 3 3, Phase 1/2 1, Phase 1 3) 2025: 64 trials (Observational 9, Not applicable 53, Phase 4 1, Phase 1 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 36
2025 64
2024 73
2023 51
2022 58
2021 41
2020 46
2019 45
2018 50
2017 32

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.